D. E. Shaw & Co., Inc. Biocryst Pharmaceuticals Inc Put Options Transaction History
D. E. Shaw & Co., Inc.
- $114 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BCRX
# of Institutions
256Shares Held
182MCall Options Held
839KPut Options Held
816K-
Black Rock Inc. New York, NY18.4MShares$118 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.7MShares$113 Million0.0% of portfolio
-
State Street Corp Boston, MA17.5MShares$112 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY13.1MShares$83.7 Million0.8% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$64.9 Million0.65% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.19B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...